HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A comparison of gastro-oesophageal reflux in volunteers assessed by ambulatory pH and gamma monitoring after treatment with either Liquid Gaviscon or Algicon Suspension.

Abstract
This study was designed to compare the effectiveness of single doses of either Liquid Gaviscon or Algicon Suspension in the suppression of food and acid reflux into the oesophagus after a test meal in volunteers. After the pH electrode and gamma detector were positioned 5 cm above the cardia, the volunteers received a refluxogenic radiolabelled meal. The subjects then remained untreated, or thirty minutes later they were given a dose of unlabelled Algicon Suspension, or Liquid Gaviscon and a recording was made for a minimum of 3 hours. Allocation to the treatment group was randomized with the cross-overs performed 1 week apart. Liquid Gaviscon suppressed gastro-oesophageal reflux of both food and acid whereas only an insignificant reduction in reflux was seen after Algicon Suspension. The oesophageal pH remained below 4 for 3.21 +/- 0.92% (S.E.M.) of the recording period in the control study, 0.88 +/- 0.33 after Gaviscon and 2.91 +/- 0.68 after Algicon. The reflux of food was reduced from 17,070 x 10(3) +/- 4713 x 10(3) counts in the control study to 224 x 10(3) +/- 93 x 10(3) counts after the Gaviscon and 16,080 x 10(3) +/- 7131 x 10(3) counts after Algicon. The suppression of reflux by Liquid Gaviscon was significantly better than that produced by Algicon Suspension.
AuthorsN Washington, J L Greaves, S Y Iftikhar
JournalAlimentary pharmacology & therapeutics (Aliment Pharmacol Ther) Vol. 6 Issue 5 Pg. 579-88 (Oct 1992) ISSN: 0269-2813 [Print] England
PMID1420749 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Alginates
  • Antacids
  • Bicarbonates
  • Carbonates
  • Drug Combinations
  • Algicon
  • Silicic Acid
  • Aluminum Hydroxide
  • alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination
  • Technetium
  • Sodium Bicarbonate
Topics
  • Adult
  • Alginates (therapeutic use)
  • Aluminum Hydroxide (therapeutic use)
  • Ambulatory Care (methods)
  • Antacids (therapeutic use)
  • Bicarbonates (therapeutic use)
  • Calibration
  • Carbonates (therapeutic use)
  • Drug Combinations
  • Electrodes, Implanted
  • Esophagus (diagnostic imaging, metabolism)
  • Female
  • Food
  • Gamma Cameras
  • Gastroesophageal Reflux (prevention & control)
  • Humans
  • Hydrogen-Ion Concentration
  • Male
  • Monitoring, Physiologic
  • Radionuclide Imaging
  • Silicic Acid (therapeutic use)
  • Sodium Bicarbonate
  • Technetium

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: